BofA Adjusts Price Target on ArcBest to $98 From $99, Maintains Underperform Rating
TD Cowen Downgrades ArcBest(ARCB.US) to Hold Rating, Cuts Target Price to $114
ArcBest Downgraded to Hold From Buy at TD Cowen
ArcBest Is Maintained at Buy by Jefferies
Jefferies Maintains ArcBest(ARCB.US) With Buy Rating, Cuts Target Price to $130
Goldman Sachs Maintains ArcBest(ARCB.US) With Hold Rating, Cuts Target Price to $125
ArcBest Analyst Ratings
Citi Maintains ArcBest(ARCB.US) With Hold Rating, Cuts Target Price to $111
J.P. Morgan Maintains ArcBest(ARCB.US) With Hold Rating, Cuts Target Price to $130
Wolfe Research Downgrades ArcBest(ARCB.US) to Hold Rating
ArcBest Initiated With a Neutral at Citi
Morgan Stanley Maintains ArcBest(ARCB.US) With Buy Rating, Maintains Target Price $175
Wells Fargo Maintains ArcBest(ARCB.US) With Hold Rating, Maintains Target Price $112
Wells Fargo Remains a Hold on ArcBest (ARCB)
Stephens Maintains ArcBest(ARCB.US) With Buy Rating, Cuts Target Price to $123
J.P. Morgan Maintains ArcBest(ARCB.US) With Hold Rating, Cuts Target Price to $133
TD Cowen Maintains ArcBest(ARCB.US) With Buy Rating, Cuts Target Price to $131
Buy Rating Affirmed for ArcBest With Positive Revenue Trends and Strong Future Growth Prospects
ArcBest Cut to Equal-Weight From Overweight by Wells Fargo
BofA Securities Maintains ArcBest(ARCB.US) With Sell Rating, Maintains Target Price $99
No Data
No Data